These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34748351)

  • 21. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J; Olle B; Suhail H; Felicella MM; Giri S
    J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.
    van de Beek MC; Dijkstra IM; van Lenthe H; Ofman R; Goldhaber-Pasillas D; Schauer N; Schackmann M; Engelen-Lee JY; Vaz FM; Kulik W; Wanders RJ; Engelen M; Kemp S
    PLoS One; 2016; 11(4):e0154597. PubMed ID: 27124591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease inhibitors suppress the degradation of mutant adrenoleukodystrophy proteins but do not correct impairment of very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.
    Yamada T; Shinnoh N; Kobayashi T
    Neurochem Res; 1997 Mar; 22(3):233-7. PubMed ID: 9051655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.
    Hartley MD; Kirkemo LL; Banerji T; Scanlan TS
    Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
    Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP.
    Pahan K; Khan M; Singh I
    J Lipid Res; 1998 May; 39(5):1091-100. PubMed ID: 9610777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous Addition of 25-Hydroxycholesterol Reduces Level of Very Long-Chain Fatty Acids in X-Linked Adrenoleukodystrophy.
    Jang J; Lee JW; Song J; Kim DW; Min KH
    ChemistryOpen; 2019 Feb; 8(2):188-191. PubMed ID: 30788208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.
    Fourcade S; Ruiz M; Guilera C; Hahnen E; Brichta L; Naudi A; Portero-Otín M; Dacremont G; Cartier N; Wanders R; Kemp S; Mandel JL; Wirth B; Pamplona R; Aubourg P; Pujol A
    Hum Mol Genet; 2010 May; 19(10):2005-14. PubMed ID: 20179078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
    Baarine M; Beeson C; Singh A; Singh I
    J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency.
    Oezen I; Rossmanith W; Forss-Petter S; Kemp S; Voigtländer T; Moser-Thier K; Wanders RJ; Bittner RE; Berger J
    Hum Mol Genet; 2005 May; 14(9):1127-37. PubMed ID: 15772093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases.
    Jia Z; Pei Z; Li Y; Wei L; Smith KD; Watkins PA
    Mol Genet Metab; 2004; 83(1-2):117-27. PubMed ID: 15464426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening for carrier and prenatal diagnosis of X-linked adrenoleukodystrophy].
    Wang AH; Bao XH; Xiong H; Pan H; Wu Y; Zhang YH; Shi CY; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):345-9. PubMed ID: 15924749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling and Imaging of Phospholipids in Brains of Abcd1-Deficient Mice.
    Hama K; Fujiwara Y; Morita M; Yamazaki F; Nakashima Y; Takei S; Takashima S; Setou M; Shimozawa N; Imanaka T; Yokoyama K
    Lipids; 2018 Jan; 53(1):85-102. PubMed ID: 29469952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
    Weinhofer I; Forss-Petter S; Zigman M; Berger J
    Hum Mol Genet; 2002 Oct; 11(22):2701-8. PubMed ID: 12374760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy.
    van de Beek MC; Ofman R; Dijkstra I; Wijburg F; Engelen M; Wanders R; Kemp S
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2255-2265. PubMed ID: 28666219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice.
    Netik A; Hobel A; Rauschka H; Molzer B; Forss-Petter S; Berger J
    J Inherit Metab Dis; 2000 Sep; 23(6):615-24. PubMed ID: 11032336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy.
    Khan M; Singh J; Gilg AG; Uto T; Singh I
    J Lipid Res; 2010 Jul; 51(7):1685-95. PubMed ID: 20173212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients.
    Jang J; Kang HC; Kim HS; Kim JY; Huh YJ; Kim DS; Yoo JE; Lee JA; Lim B; Lee J; Yoon TM; Park IH; Hwang DY; Daley GQ; Kim DW
    Ann Neurol; 2011 Sep; 70(3):402-9. PubMed ID: 21721033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dominant
    Kutkowska-Kaźmierczak A; Rydzanicz M; Chlebowski A; Kłosowska-Kosicka K; Mika A; Gruchota J; Jurkiewicz E; Kowalewski C; Pollak A; Stradomska TJ; Kmieć T; Jakubowski R; Gasperowicz P; Walczak A; Śladowski D; Jankowska-Steifer E; Korniszewski L; Kosińska J; Obersztyn E; Nowak W; Śledziński T; Dziembowski A; Płoski R
    J Med Genet; 2018 Jun; 55(6):408-414. PubMed ID: 29496980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy.
    McGuinness MC; Lu JF; Zhang HP; Dong GX; Heinzer AK; Watkins PA; Powers J; Smith KD
    Mol Cell Biol; 2003 Jan; 23(2):744-53. PubMed ID: 12509471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.